Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial mannitol-specific phosphotransferase system (PTS), Enzyme II complex (EIIMtl), is a specialized multi-domain protein or complex that mediates the active transport and concomitant phosphorylation of mannitol in various bacterial species [1, 4, 8]. It typically comprises three functional domains: EIIA, EIIB, and EIIC, which may be fused into a single polypeptide (often encoded by the mtlA gene) or exist as separate subunits [3, 11, 27]. The EIIC domain forms the transmembrane channel for mannitol translocation, while the EIIA and EIIB domains participate in a phosphoryl relay that transfers a phosphate group from phosphoenolpyruvate (PEP) to the incoming sugar [23, 27]. Beyond its primary role in carbohydrate metabolism, EIIMtl acts as a sensory and regulatory component, influencing virulence factor expression and biofilm formation in pathogens such as Vibrio cholerae and Staphylococcus aureus [1, 3, 35]. Because the PTS is unique to bacteria and absent in eukaryotes, it is considered a promising target for the development of novel antimicrobial agents designed to disrupt bacterial energy acquisition and pathogenesis [6, 16, 19]. Experimental inhibitors such as N-ethylmaleimide and potassium ferricyanide have been shown to modulate its activity in research settings [2, 7, 30].
The complex facilitates the uptake of extracellular mannitol and its simultaneous phosphorylation to mannitol-1-phosphate using a phosphoryl group derived from phosphoenolpyruvate (PEP), which is transferred through Enzyme I (EI) and HPr to the EIIA, EIIB, and finally to the sugar during transport through the EIIC membrane channel [8, 23, 27].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial mannitol-specific phosphotransferase system, Enzyme II complex (EIIMtl).